Craft

Nimbus Therapeutics

Total Funding

$242 M

Nimbus Therapeutics Summary

Company Summary

Overview
Nimbus Therapeutics is a biotechnology company which operates an application of computational chemistry to design treatments for substantial and underserved human diseases. The Company aims to disrupt known drivers of serious diseases, including metabolic disease, cancer, and immune-inflammatory disorders.
Type
Private
Status
Active
Founded
2009
HQ
Cambridge, MA, US | view all locations
Website
https://www.nimbustx.com/
Cybersecurity rating
Sectors

Key People

  • George P Vlasuk

    George P Vlasuk, President and CSO, Navitor Pharmaceuticals

  • Scott Edmondson

    Scott Edmondson, Senior Vice President, Head of Chemistry

  • Erin Cowhig

    Erin Cowhig, Chief People Officer

  • Jeb Keiper

    Jeb Keiper, Chief Executive Officer, Director

LocationsView all

1 location detected

  • Cambridge, MA HQ

    United States

    130 Prospect St #301Cambridge

Footer menu